Cite
Rosiglitazone and glimeperide: review of clinical results supporting a fixed dose combination
MLA
Andreas Pfützner, et al. “Rosiglitazone and Glimeperide: Review of Clinical Results Supporting a Fixed Dose Combination.” Vascular Health and Risk Management, vol. ume 3, May 2007, pp. 211–20. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.6cb91eb75cc946e1a32a2c968cfa9acc&authtype=sso&custid=ns315887.
APA
Andreas Pfützner, Birgit Wilhelm, & Thomas Forst. (2007). Rosiglitazone and glimeperide: review of clinical results supporting a fixed dose combination. Vascular Health and Risk Management, ume 3, 211–220.
Chicago
Andreas Pfützner, Birgit Wilhelm, and Thomas Forst. 2007. “Rosiglitazone and Glimeperide: Review of Clinical Results Supporting a Fixed Dose Combination.” Vascular Health and Risk Management ume 3 (May): 211–20. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.6cb91eb75cc946e1a32a2c968cfa9acc&authtype=sso&custid=ns315887.